AdaptHealth Shares Fall As Q2 Profits Come Below Expectation, Reaffirms Annual Guidance

  • AdaptHealth Corp AHCO delivered Q2 revenue of $727.6 million, +17.9% Y/Y, beating the consensus of $724.22 million.
  • Adjusted EBITDA reached $150 million, +1.8% Y/Y.
  • The company said that Q2 revenue and Adjusted EBITDA are consistent with internal expectations as it continues to overcome challenges resulting from industry shortages of CPAP equipment.
  • On a sequential basis, the adjusted EBITDA margin increased 110 basis points to 20.6%, as the company continues to manage through the inflationary environment and supply chain challenges.
  • The company reported EPS of $0.09, down from $0.12 a year ago and the consensus of $0.26.
  • Cash flow from operations was $103.5 million.
  • AdaptHealth says sleep categories showed strong sequential growth as the supply of PAP machines continues to improve relative to recent quarters.
  • Guidance: AdaptHealth reaffirms FY22 sales of $2.84 - $3.04 billion versus the consensus of $2.96 billion.
  • It forecasts adjusted EBITDA of $615-$675 million.
  • Price Action: AHCO shares are down 14.50% at $22 during the market session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!